Prevalent vertebral fractures among children initiating glucocorticoid therapy for the treatment of rheumatic disorders.
OBJECTIVE
Vertebral fractures are an under-recognized problem in children with inflammatory disorders. We studied spine health among 134 children (87 girls) with rheumatic conditions (median age 10 years) within 30 days of initiating glucocorticoid therapy.


METHODS
Children were categorized as follows: juvenile dermatomyositis (n = 30), juvenile idiopathic arthritis (n = 28), systemic lupus erythematosus and related conditions (n = 26), systemic arthritis (n = 22), systemic vasculitis (n = 16), and other conditions (n = 12). Thoracolumbar spine radiograph and dual x-ray absorptiometry for lumbar spine (L-spine) areal bone mineral density (BMD) were performed within 30 days of glucocorticoid initiation. Genant semiquantitative grading was used for vertebral morphometry. Second metacarpal morphometry was carried out on a hand radiograph. Clinical factors including disease and physical activity, calcium and vitamin D intake, cumulative glucocorticoid dose, underlying diagnosis, L-spine BMD Z score, and back pain were analyzed for association with vertebral fracture.


RESULTS
Thirteen vertebral fractures were noted in 9 children (7%). Of these, 6 patients had a single vertebral fracture and 3 had 2-3 fractures. Fractures were clustered in the mid-thoracic region (69%). Three vertebral fractures (23%) were moderate (grade 2); the others were mild (grade 1). For the entire cohort, mean +/- SD L-spine BMD Z score was significantly different from zero (-0.55 +/- 1.2, P < 0.001) despite a mean height Z score that was similar to the healthy average (0.02 +/- 1.0, P = 0.825). Back pain was highly associated with increased odds for fracture (odds ratio 10.6 [95% confidence interval 2.1-53.8], P = 0.004).


CONCLUSIONS
In pediatric rheumatic conditions, vertebral fractures can be present prior to prolonged glucocorticoid exposure.
Huber
A M
AM
Dalhousie University, Halifax, Nova Scotia, Canada.
Gaboury
I
I
Cabral
D A
DA
Lang
B
B
Ni
A
A
Stephure
D
D
Taback
S
S
Dent
P
P
Ellsworth
J
J
LeBlanc
C
C
Saint-Cyr
C
C
Scuccimarri
R
R
Hay
J
J
Lentle
B
B
Matzinger
M
M
Shenouda
N
N
Moher
D
D
Rauch
F
F
Siminoski
K
K
Ward
L M
LM
D015502:Absorptiometry, Photon; D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D005260:Female; D005938:Glucocorticoids / Q000009:adverse effects*; D006801:Humans; D007223:Infant; D008159:Lumbar Vertebrae / Q000000981:diagnostic imaging / Q000293:injuries*; D008297:Male; D016017:Odds Ratio; D012216:Rheumatic Diseases / Q000188:drug therapy*; D016103:Spinal Fractures / Q000139:chemically induced*; D013904:Thoracic Vertebrae / Q000293:injuries*
D005938:Glucocorticoids
Ann Rheum Dis. 2006 Aug;65(8):1074-9
16627541
Arthritis Rheum. 2007 Jun;56(6):1966-73
17530722
Stat Med. 1998 Apr 30;17(8):857-72
9595616
Joint Bone Spine. 2003 Feb;70(1):40-5
12639616
Arch Dis Child. 1970 Feb;45(239):13-23
5440182
J Rheumatol. 2005 Apr;32(4):729-33
15801032
Osteoporos Int. 2000;11(1):25-30
10663355
Rheumatology (Oxford). 2004 Sep;43(9):1186-9
15226518
Braz J Med Biol Res. 2002 Oct;35(10):1159-63
12424488
J Bone Miner Res. 1999 May;14(5):821-8
10320531
Int J Obes Relat Metab Disord. 2002 Apr;26(4):538-43
12075581
Scand J Rheumatol. 2008 Jan-Feb;37(1):40-7
18189194
J Bone Miner Res. 2000 Mar;15(3):564-74
10750572
Arthritis Rheum. 2003 Aug;48(8):2294-8
12905484
Clin Exp Rheumatol. 2005 Jan-Feb;23(1):113-6
15789898
J Endocrinol Invest. 1996 Mar;19(3):165-9
8743282
Osteoporos Int. 2000;11(8):680-7
11095171
Arthritis Rheum. 2005 Mar;52(3):833-40
15751052
Invest Radiol. 1968 Jan-Feb;3(1):27-34
5637127
Osteoporos Int. 1999;9(3):206-13
10450408
Arch Dis Child. 1969 Jun;44(235):291-303
5785179
Arthritis Rheum. 2000 Mar;43(3):531-40
10728745
Arthritis Rheum. 1996 May;39(5):746-57
8639171
Calcif Tissue Int. 1987 Aug;41(2):75-8
3115548
J Bone Miner Res. 2009 Jul;24(7):1326-34
19210218
Clin Rheumatol. 1998;17(6):551-3
9890693
J Bone Miner Res. 1993 Sep;8(9):1137-48
8237484
Horm Res. 2000;54 Suppl 1:58-63
11146381
Scand J Rheumatol. 1999;28(1):19-26
10092160
J Rheumatol. 1998 May;25(5):990-2
9598904
Pediatr Pulmonol. 2008 Apr;43(4):345-53
18306334
J Rheumatol. 2004 May;31(5):981-5
15124261
Ann Saudi Med. 2007 Nov-Dec;27(6):427-31
18059123
Rheumatol Int. 2003 May;23(3):127-9
12739043
Arthritis Rheum. 2003 Aug;48(8):2214-23
12905475
J Pediatr. 2009 Mar;154(3):438-43
18950793
Arthritis Rheum. 2007 Mar;56(3):977-83
17328075
Pediatrics. 1993 Jun;91(6):1127-30
8502514
Braz J Med Biol Res. 2005 Feb;38(2):309-13
15785843
J Rheumatol. 2007 Apr;34(4):831-6
17309121
Arthritis Rheum. 2005 Jul;52(7):2051-9
15986346
Lupus. 2008 Sep;17(9):787-92
18755859
Ann Rheum Dis. 1995 Mar;54(3):193-6
7748017
Osteoporos Int. 2007 Oct;18(10):1405-10
17468808
Arthritis Rheum. 1997 Nov;40(11):1967-75
9365085
J Am Diet Assoc. 1989 Oct;89(10):1484-8
2794308
Rheumatol Int. 1998;18(2):45-9
9782532
Clin Exp Rheumatol. 1998 Jul-Aug;16(4):495-501
9706436
Bone. 2003 Oct;33(4):522-32
14555255
Arthritis Rheum. 1997 Nov;40(11):1976-83
9365086
Pediatrics. 2002 Jan;109(1):45-60
11773541